MedPath

The Effect of Nefopam on Catheter-related Bladder Discomfort

Not Applicable
Completed
Conditions
Nefopam
Catheter-related Bladder Discomfort
Interventions
Registration Number
NCT03130010
Lead Sponsor
Seoul National University Hospital
Brief Summary

In the present study, the investigators evaluated whether nefopam 20 mg reduce the catheter-related bladder discomfort in patients undergoing foley catheter insertion

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
110
Inclusion Criteria
  1. Patients scheduled to insert the catheter a new foley catheter more than 14 Fr in the operation site,
  2. Adults 20 to 75years of age
  3. American Society of Anesthesiologists Physical Classification 1,2 patients
  4. Patients who pre-agreed to the study
  5. Male patient
Exclusion Criteria
  1. Neurogenic bladder
  2. Patients diagnosed with irritable bladder
  3. study drug sensitive or contraindicated
  4. Patients with central nervous system or neurological disorder (epilepsy, patients receiving MAO inhibitor)
  5. Patients with urethral and prostate disorders
  6. Patients with previous history of myocardial infarction
  7. Patients with closed angle glaucoma

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
The control groupNefopam or salineOne hour before the end of the operation, the control group was received 20 ml of saline.
The Nefopam groupNefopam or salineOne hour before the end of the operation, the Nefopam group was received 20 mg of nefopam.
Primary Outcome Measures
NameTimeMethod
catheter-related bladder discomfortpostoperative 1 hour

assessment of catheter-related bladder discomfort using visual analogue scale

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Seoul National Univ. Bundang Hospital

🇰🇷

Seongnam-si, Gyeonggi-do, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath